Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 290661011000036111 | palivizumab 50 mg injection, 50 mg vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 290662011000036117 | palivizumab 50 mg injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| palivizumab 50 mg injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| palivizumab 50 mg injection, vial | Is a | palivizumab | true | Inferred relationship | Some | ||
| palivizumab 50 mg injection, vial | has intended active ingredient | palivizumab | true | Inferred relationship | Some | 1653079020 | |
| palivizumab 50 mg injection, vial | has Australian BoSS | palivizumab | true | Inferred relationship | Some | 1653079020 | |
| palivizumab 50 mg injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| palivizumab 50 mg injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1653079021 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Synagis (palivizumab 50 mg) powder for injection, 50 mg vial | Is a | True | palivizumab 50 mg injection, vial | Inferred relationship | Some | |
| palivizumab 50 mg injection [1 vial] (&) inert substance diluent [1 mL ampoule], 1 pack | has MPUU | True | palivizumab 50 mg injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Australian dialect reference set
Description inactivation indicator reference set
Medicinal product unit of use reference set
FHIR